These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2829533)

  • 1. In vivo and in vitro models of demyelinating disease, XXI: relationship between differentiation of rat oligodendrocytes and control of JHMV replication.
    Beushausen S; Dales S
    Adv Exp Med Biol; 1987; 218():239-54. PubMed ID: 2829533
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.
    Beushausen S; Narindrasorasak S; Sanwal BD; Dales S
    J Virol; 1987 Dec; 61(12):3795-803. PubMed ID: 2824815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of MHV-4 infection of astrocytes and oligodendrocytes in vitro.
    Knobler RL; Cole R; de Vellis J; Lewicki H; Buchmeier MJ; Oldstone MB
    Adv Exp Med Biol; 1987; 218():231-7. PubMed ID: 2829532
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro models of demyelinating diseases. XV. Differentiation influences the regulation of coronavirus infection in primary explants of mouse CNS.
    Wilson GA; Beushausen S; Dales S
    Virology; 1986 Jun; 151(2):253-64. PubMed ID: 3010553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of the nucleocapsid protein of inoculum JHMV may be essential for initiating replication.
    Kalicharran K; Dales S
    Adv Exp Med Biol; 1995; 380():485-9. PubMed ID: 8830528
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro models of demyelinating disease. Possible relationship between induction of regulatory subunit from cAMP dependent protein kinases and inhibition of JHMV replication in cultured oligodendrocytes.
    Wilson GA; Mohandas DV; Dales S
    Adv Exp Med Biol; 1990; 276():261-6. PubMed ID: 1966411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of caspase-dependent apoptosis in cultured rat oligodendrocytes by murine coronavirus is mediated during cell entry and does not require virus replication.
    Liu Y; Cai Y; Zhang X
    J Virol; 2003 Nov; 77(22):11952-63. PubMed ID: 14581532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro models of demyelinating diseases.
    Sorensen O; Coulter-Mackie M; Percy D; Dales S
    Adv Exp Med Biol; 1981; 142():271-86. PubMed ID: 6278886
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of the initiation of coronavirus JHM infection in primary oligodendrocytes and L-2 fibroblasts.
    Kalicharran K; Mohandas D; Wilson G; Dales S
    Virology; 1996 Nov; 225(1):33-43. PubMed ID: 8918531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro models of demyelinating disease. XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS.
    Beushausen S; Dales S
    Virology; 1985 Feb; 141(1):89-101. PubMed ID: 2983498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.
    Pasick JM; Dales S
    J Virol; 1991 Sep; 65(9):5013-28. PubMed ID: 1651420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regeneration of oligodendroglia during recovery from demyelinating disease.
    Herndon RM; Price DL; Weiner LP
    Science; 1977 Feb; 195(4279):693-4. PubMed ID: 190678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.
    Ghandour MS; Feutz AC; Jalabi W; Taleb O; Bessert D; Cypher M; Carlock L; Skoff RP
    Glia; 2002 Dec; 40(3):300-11. PubMed ID: 12420310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice.
    Godfraind C; Friedrich VL; Holmes KV; Dubois-Dalcq M
    J Cell Biol; 1989 Nov; 109(5):2405-16. PubMed ID: 2553746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.
    Wilson GA; Dales S
    J Virol; 1988 Sep; 62(9):3371-7. PubMed ID: 2841490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS).
    Erlich SS; Fleming JO; Stohlman SA; Weiner LP
    Arch Neurol; 1987 Aug; 44(8):839-42. PubMed ID: 2820360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro models of demyelinating disease, XXIII: Infection by JHM virus of athymic rats.
    Sorensen O; Saravani A; Dales S
    Adv Exp Med Biol; 1987; 218():383-90. PubMed ID: 2829549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-induced demyelination in mice: "dying back" of oligodendrocytes.
    Rodriguez M
    Mayo Clin Proc; 1985 Jul; 60(7):433-8. PubMed ID: 4040195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The severity of hepatic lesion after intraperitoneal JHMV infection in IFN-gamma deficient mice is parallel to viral replication in hepatocytes in vitro.
    Kyuwa S; Kawamura S; Shibata S; Machii K; Tagawa Y; Iwakura Y; Urano T
    Adv Exp Med Biol; 2001; 494():95-9. PubMed ID: 11774552
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.
    Sorensen O; Perry D; Dales S
    Arch Neurol; 1980 Aug; 37(8):478-84. PubMed ID: 6251790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.